(Reuters) – U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was developed by Gilead Science Inc’s Kite Pharma, marking the second approval for this potentially revolutionary approach to fighting cancer.
WASHINGTON (Reuters) – A bipartisan deal from two senators to stabilize Obamacare by restoring subsidies to health insurers suffered major setbacks on Wednesday with the White House saying President Donald Trump now opposes it and senior Republicans speaking out against it.
After Hurricane Maria toppled the bridge that connects him to the rest of civilization and ripped the roof and walls off his house here in the central mountains of Puerto Rico, Ramón Sostre raised a weathered American flag above the wreckage.
For 22 years, Deputy Charles Johnson has started his workday by putting on his police uniform.
(Reuters) – A U.S. judge’s ruling on Monday invalidating Allergan Plc’s patents on its blockbuster $1.5 billion dry-eye medicine, Restasis, has cast doubt on the company’s novel strategy to enlist a Native American tribe to help shield those patents from challenge by generic drugmakers, legal experts said.
(Reuters) – Johnson & Johnson on Tuesday won the reversal of a $72 million verdict in favor of the family of a woman whose death from ovarian cancer they claimed stemmed from her use of the company’s talc-based products like Johnson’s Baby Powder.
Sammy Rolon is living in a makeshift clinic set up at a school. He has cerebral palsy and epilepsy, and is bed-ridden. He’s waiting for surgery that was scheduled before Hurricane Maria smashed into Puerto Rico. Now he can’t even get the oxygen he needs.
WASHINGTON (Reuters) – U.S. President Donald Trump said on Monday that he would “look into” a report that his nomination for drug czar championed a law weakening the Drug Enforcement Administration’s capacity to slow the flow of drugs that have fueled the country’s opioid epidemic.
Pollution affects us even in the womb: Women who are exposed to air pollution during pregnancy have babies with shorter telomeres (a genetic biomarker), a study published Monday in JAMA Pediatrics found.
(Reuters) – Aimmune Therapeutics Inc said on Monday it would collaborate with Regeneron Pharmaceuticals Inc and Sanofi to develop its experimental peanut allergy drug.